Coutts Margaret, Keirstead Hans S
Reeve-Irvine Research Center, Stem Cell Research Center, Department of Anatomy and Neurobiology, College of Medicine, University of California Irvine, Irvine, CA, USA.
Exp Neurol. 2008 Feb;209(2):368-77. doi: 10.1016/j.expneurol.2007.09.002. Epub 2007 Sep 12.
This article reviews stem cell-based strategies for spinal cord injury repair, and practical issues concerning their translation to the clinic. Recent progress in the stem cell field includes clinically compliant culture conditions and directed differentiation of both embryonic stem cells and somatic stem cells. We provide a brief overview of the types of stem cells under evaluation, comparing their advantages and disadvantages for use in human clinical trials. We review the practical considerations and risks that must be addressed before human treatments can begin. With a growing understanding of these practical issues, stem cell biology, and spinal cord injury pathophysiology, stem cell-based therapies are moving closer to clinical application.
本文综述了基于干细胞的脊髓损伤修复策略及其转化至临床所涉及的实际问题。干细胞领域的最新进展包括符合临床标准的培养条件以及胚胎干细胞和体干细胞的定向分化。我们简要概述了正在评估的干细胞类型,比较了它们在人类临床试验中的优缺点。我们回顾了在开始人类治疗之前必须解决的实际考虑因素和风险。随着对这些实际问题、干细胞生物学和脊髓损伤病理生理学的认识不断加深,基于干细胞的疗法正朝着临床应用迈进。